The relative ability of the calcium chelates of calcium disodium ethylenediaminetetraacetate (EDTA) and calcium trisodium ethylenetriaminepentaacetate (DTPA) to protect mice against lethal doses of Clostridium perfringens a-toxin was investigated. Their protective ability was assayed by the increase in survival time of mice which had been given large doses of toxin, and by determining the median protective dose of chelate that would protect mice against toxin at a minimum lethal dose of two. In both assay procedures, intraperitoneal, intravenous, and intracutaneous injections of toxin were utilized, and with each toxin injection route the protective ability of the chelate was determined with the three routes of injection. DTPA was 10 to 20 times more effective than EDTA with both types of assay procedure and with all injection routes. DTPA may be superior to EDTA as a protective agent not only because it binds zinc to a greater extent, but also because of its greater retention in the body and its ability to gain entrance into cells. It appears that DTPA may be of value as a therapeutic agent in gas-gangrene.
The a-toxin of Clostridium perfringens, a lecithinase (phospholipase-C), is considered to be the lethal factor in gas-gangrene (6) . Zinc, cobalt, or calcium is required for its in vivo and in vitro activity (7, 10) , and it has been demonstrated that a chelating agent, calcium disodium ethylenediaminetetraacetate (EDTA), could protect animals against lethal amounts of the toxin or experimental infections produced with the organism (8) . The action of the chelating agent is undoubtedly related to its metal-binding capacity, inasmuch as its inhibition of the toxin can be reversed by metals in vivo and in vitro (10) . The degree of protection afforded animals was found to be related to the dose of chelating agent and the time of its administration after injection of toxin (9) . It appears that the chelate acts by maintaining a low level of free metal ions which reduce the activity of the a-toxin.
To further elucidate the mode of action of chelating agents in protecting against the toxin, and in an attempt to find a chelating agent that would be more efficient in this respect, the comparative effectiveness of EDTA and another related polycarboxylic amino acid, calcium trisodium ethylenetriaminepentaacetate (DTPA), was studied. This latter compound was chosen because it had been shown to be retained in the body longer than EDTA and it exerts a longer beneficial effect in mobilizing heavy metals in the body (11, 13) . It penetrates to the interior of cells (A. Catsch, Federation Proc., p. 206, 1961), whereas EDTA does not, and, furthermore, the binding constant of DTPA for zinc is greater than that of EDTA. Any or all of these factors could cause DTPA to be a more beneficial protective agent than EDTA. The results of studies comparing the protection afforded by EDTA and DTPA against the toxic action of the a-toxin in mice are described in this report.
MATERIALS AND METHODS F The preparation of borate-buffered saline (BBS) and of partially purified a-toxin, and the toxin bioassay methods were described in a previous paper (5) .
Injection methods. The three parenteral routes, intraperitoneal (ip), intravenous (iv), and intracutaneous (ic), used previously (5) were used to compare the dose-effect relationships of the two chelates. The injection order was toxin first, followed immediately by the graded dose of appropriate chelating agent. The site of the ic inoculation of chelate was at a different site from that of the toxin. From (ii) DTPA (CaNa3DTPA; molecular weight, 497.) The acid crystals were supplied by Dow Chemical Co., Midland, Mich. A stock solution of 0.100 M was prepared by adding crystals to NaOH solution in the ratio of 1 mole of DTPA to 3 moles of NaOH to form the trisodium salt. The calcium chelate was then made by adding an amount of CaCI2 equal to the DTPA. Solid NaOH was added to bring the pH mean to 7.0; the final pH volume adjustments to bring the solution to 0.100 M, pH 7.35, were done volumetrically with BBS. The stock solution was stored in a polyethylene bottle at 4 C. Prior to use, it was diluted with sterile BBS to contain the desired dose in 0.25 ml for injection. The LD50 of this reagent was about 400 ,imoles via the ip route.
RESULTS
In an accompanying report (5) , it was noted that there were variations in the sensitivity of nmice to the a-toxin with different routes of injection and with toxin preparations of different degrees of purity. These variations should be considered in a quantitative analysis of protection afforded by chelating agents against the toxin. Accordingly, the three routes employed previously for the injection of toxin were utilized, and three different routes of chelate injection were used for each route of toxin injection. Toxin preparations prepared according to procedure B, which gave the least variation in response to the toxin (5), were utilized.
Two methods were used for comparing the effects of the chelating agents: (i) the effect of graded doses of chelates on median survival time (ST5o) response to toxin, and (ii) estimation of median protective dose (PD50) of EDTA and DTPA.
Protective effects of graded doses of EDTA and DTPA on STbo response to toxin. All the mice which received toxin injections via the ip or iv routes were given a dose equal to 32 MLD (minimum lethal dose). At The protection provided by the same doses of chelates when the toxin was given iv is given in Table 2 . In these experiments, the contrast between the effectiveness of DTPA and EDTA is even greater than when the toxin was injected ip; only DTPA showed any measurable protection up to 5 ,umoles dosage, and this increased until the optimum dosage of about 10 ,Mmoles. The benefits provided by the ic and ip injection of the chelates are at the same general level obtained when the toxin was given ip, and much less protection was afforded when the chelate was given iv.
The results of experiments with the toxin given ic are presented in Table 3 . DTPA was markedly superior to EDTA with all routes of administration. With 5 ,umoles of DTPA, a large proportion of the animals survived with the iv and the ip route of administration. All the survivors showed signs of illness, but recovered by the next day and survived during the following week of observation.
Estimation of PD50 of EDTA and DTPA. The amount of toxin with which all animals would die within 6, 12, and 18 hr after injection when given by the ip, iv, and ic routes, respectively, was determined (approximately 2 MLD) and utilized in these experiments. Control groups receiving toxin alone were included in the following experiments; in all cases the mice died within the predicted times.
Groups of 10 mice were given the appropriate injection of toxin and were then injected with the various doses of the two chelates which had been selected on the basis of preliminary tests. The numbers of dead and survivors were noted in each group after 6, 12, 18, and 24 hr. Each experiment was carried out twice with essentially identical results. Cumulative percentages of survivors from both series were pooled and tabulated (1). These data were plotted on a dose-response curve by using probability-timeslogarithmic-scale graphic charts (Keuffel & Esser, no. 359-24). For this purpose, the doses were converted to micromoles per kilogram of body weight by multiplying with a common (Fig. 1, 2 , and 3). In drawing the lines, the common practice of "fitting by eye" has been followed, with favor to points between 15 and 85%o, because reliability of results decreases as they approach 0 and 100%C (3, 12) . Where the dose-response curves intersect the 50%, survivor line on the graph, the PD50 may be read from the dosage scale. A summary of the PD50 estimated from these figures is presented in Table 4 . With the various route combinations of toxin and chelate, the protection afforded by a given dose of DTPA is approximately 10 to 20 times greater than with EDTA. It appears that the dose response with both DTPA and EDTA is greatest when the chelate is administered by the same route as the toxin, although there is little difference in the Fig. 1, 2 , and 3.
amount of DTPA required with all three routes when the toxin was given iv and ic.
DISCUSSION
It is apparent that DTPA is much more efficient than EDTA in its ability to protect mice against the lethal effects of the toxin. This was observed with the three routes of inoculation used and with both types of assay procedure that were utilized.
Although the stability constants of DTPA and EDTA with calcium are essentially the same, DTPA binds zinc to a much greater extent than does EDTA (stability constants of 18.14 and 16.58, respectively). It was previously demonstrated that zinc may be the metal responsible for the activity of the a-toxin in vivo (10) , and the greater effectiveness of DTPA in protecting against the toxin is perhaps due to its ability to bind zinc to a greater extent than does EDTA. Recent studies in this laboratory (Senff and Moskowitz, unpublished data) on the relative ability of DTPA and EDTA to inhibit a-toxin lecithinase activity in vitro demonstrated that the same relative differences observed in the activity of DTPA and EDTA in vivo are also observed in vitro. These studies suggest that some, if not all, of the greater protective activity of DTPA is due to its effect on the reaction of lecithinase with its substrate in vivo.
However, the possibility that the differences in the physiological behavior of DTPA and EDTA also plays a role cannot be excluded. Indeed, the variation in the effectiveness of the different chelates by the different routes of administration suggest that these physiological factors do play a role in the differences in their activity. In a previous paper (5) , it was suggested that the activity of the toxin was markedly different by different routes, perhaps owing to a "critical site" at which the toxin acts. There is also evidence that the site of action of the a-toxin in the cell is at the mitochondrial phospholipids (2) . Thus, the greater retentive ability of DTPA, and the possibility that it is able to gain entrance to cells, may permit it to inhibit the toxin to a greater extent before the toxin gets to the "critical site," and it may continue its inhibitory activity once the toxin gets to the "critical site." It is of interest ( Table 1) that, for the ip route of inoculation of toxin, the PD50 of DTPA is much lower by the ip route than the other two routes. However, with the iv and ic routes of inoculation of toxin, the PD50 of DTPA is not greatly different with all three routes of administration. If the greater effectiveness of toxin administered by the ip route is due to its ability to rapidly gain access to a "critical site" for toxin action, the chelate also would be expected to rapidly gain access to this site when given by the ip route, and thus block the action of the toxin. The fact that, when toxin was given ip, the largest amounts of DTPA were required when given by the iv and ic routes can be ascribed to the toxin getting to the "critical site" relatively rapidly; much larger amounts of chelates are required by these routes to permit a sufficient amount to get to the "critical site" in a short enough time to react with the toxin there.
Although the amount of DTPA required for protection with all three routes does not vary much when the toxin is given ip and ic, there are relatively large variations in the amount of EDTA required. These differences in the variation of the dose requirements of the two chelates under these conditions are undoubtedly a reflection of their different behavior in the body, and indicate that, if these chelates are utilized in the treatment of gas-gangrene, the response obtained with DTPA would be more uniform and predictable than with EDTA.
Although it has been observed with some substances that their activity in the body decreases when relatively large doses are administered, the decrease in activity observed with large doses of DTPA was unexpected. If the basis of its activity is the binding of a metal essential for the activity of the a-toxin, there should not be a decrease in activity with larger doses. A possible explanation of this effect is that the large amount of toxin that was utilized in these experiments altered the physiology of the mice and increased cell permeability; under these circumstances, the DTPA exerted a slight toxic effect resulting in what appears to be a slight decrease in protective ability.
The possibility that EDTA may be of value as a chemotherapeutic agent in gas-gangrene was previously suggested (8, 10) . The results obtained in this study indicate that DTPA would also be of value in the therapy of gas-gangrene and that it would be more effective than EDTA.
